116 related articles for article (PubMed ID: 10844112)
1. Prevention of pulmonary thromboembolism by NCX 4016, a nitric oxide-releasing aspirin.
Momi S; Emerson M; Paul W; Leone M; Mezzasoma AM; Del Soldato P; Page CP; Gresele P
Eur J Pharmacol; 2000 May; 397(1):177-85. PubMed ID: 10844112
[TBL] [Abstract][Full Text] [Related]
2. Nitroaspirin plus clopidogrel versus aspirin plus clopidogrel against platelet thromboembolism and intimal thickening in mice.
Momi S; Pitchford SC; Alberti PF; Minuz P; Del Soldato P; Gresele P
Thromb Haemost; 2005 Mar; 93(3):535-43. PubMed ID: 15735806
[TBL] [Abstract][Full Text] [Related]
3. Anti-thrombotic effects of a nitric oxide-releasing, gastric-sparing aspirin derivative.
Wallace JL; McKnight W; Del Soldato P; Baydoun AR; Cirino G
J Clin Invest; 1995 Dec; 96(6):2711-8. PubMed ID: 8675638
[TBL] [Abstract][Full Text] [Related]
4. A novel nitric oxide-releasing statin derivative exerts an antiplatelet/antithrombotic activity and inhibits tissue factor expression.
Rossiello MR; Momi S; Caracchini R; Giannini S; Guglielmini G; Monopoli A; Ongini E; Semeraro N; Colucci M; Gresele P
J Thromb Haemost; 2005 Nov; 3(11):2554-62. PubMed ID: 16241953
[TBL] [Abstract][Full Text] [Related]
5. Direct and irreversible inhibition of cyclooxygenase-1 by nitroaspirin (NCX 4016).
Corazzi T; Leone M; Maucci R; Corazzi L; Gresele P
J Pharmacol Exp Ther; 2005 Dec; 315(3):1331-7. PubMed ID: 16144976
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic profile and therapeutic potential of NCX 4016, a nitric oxide-releasing aspirin, for cardiovascular disorders.
Gresele P; Momi S
Cardiovasc Drug Rev; 2006; 24(2):148-68. PubMed ID: 16961726
[TBL] [Abstract][Full Text] [Related]
7. Real-time measurement of non-lethal platelet thromboembolic responses in the anaesthetized mouse.
Tymvios C; Jones S; Moore C; Pitchford SC; Page CP; Emerson M
Thromb Haemost; 2008 Feb; 99(2):435-40. PubMed ID: 18278196
[TBL] [Abstract][Full Text] [Related]
8. Effects of combination therapy with low-dose aspirin and warfarin on platelet functions after heart valve replacement.
Kobune K; Inoue M; Morikawa M; Tsuboi M; Takanami Y; Iwane Y; Kudo T
Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):153-65. PubMed ID: 1811279
[TBL] [Abstract][Full Text] [Related]
9. Picotamide protects mice from death in a pulmonary embolism model by a mechanism independent from thromboxane suppression.
Gresele P; Corona C; Alberti P; Nenci GG
Thromb Haemost; 1990 Aug; 64(1):80-6. PubMed ID: 2274931
[TBL] [Abstract][Full Text] [Related]
10. Co-administration of nitric oxide-aspirin (NCX-4016) and aspirin prevents platelet and monocyte activation and protects against gastric damage induced by aspirin in humans.
Fiorucci S; Mencarelli A; Meneguzzi A; Lechi A; Renga B; del Soldato P; Morelli A; Minuz P
J Am Coll Cardiol; 2004 Aug; 44(3):635-41. PubMed ID: 15358033
[TBL] [Abstract][Full Text] [Related]
11. The antiplatelet effects of a new nitroderivative of acetylsalicylic acid--an in vitro study of inhibition on the early phase of platelet activation and on TXA2 production.
Lechi C; Andrioli G; Gaino S; Tommasoli R; Zuliani V; Ortolani R; Degan M; Benoni G; Bellavite P; Lechi A; Minuz P
Thromb Haemost; 1996 Nov; 76(5):791-8. PubMed ID: 8950792
[TBL] [Abstract][Full Text] [Related]
12. The effect of defibrotide on thromboembolism in the pulmonary vasculature of mice and rabbits and in the cerebral vasculature of rabbits.
Paul W; Gresele P; Momi S; Bianchi G; Page CP
Br J Pharmacol; 1993 Dec; 110(4):1565-71. PubMed ID: 8306102
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of Foeniculum vulgare essential oil and anethole in an experimental model of thrombosis.
Tognolini M; Ballabeni V; Bertoni S; Bruni R; Impicciatore M; Barocelli E
Pharmacol Res; 2007 Sep; 56(3):254-60. PubMed ID: 17709257
[TBL] [Abstract][Full Text] [Related]
14. NCX 6560, a nitric oxide-releasing derivative of atorvastatin, inhibits cholesterol biosynthesis and shows anti-inflammatory and anti-thrombotic properties.
Momi S; Impagnatiello F; Guzzetta M; Caracchini R; Guglielmini G; Olivieri R; Monopoli A; Gresele P
Eur J Pharmacol; 2007 Sep; 570(1-3):115-24. PubMed ID: 17632098
[TBL] [Abstract][Full Text] [Related]
15. Endogenous nitric oxide acts as a natural antithrombotic agent in vivo by inhibiting platelet aggregation in the pulmonary vasculature.
Emerson M; Momi S; Paul W; Alberti PF; Page C; Gresele P
Thromb Haemost; 1999 Jun; 81(6):961-6. PubMed ID: 10404776
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of platelet nitric oxide production by nebivolol prevents thrombosis.
Momi S; Caracchini R; Falcinelli E; Evangelista S; Gresele P
Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):820-9. PubMed ID: 24558107
[TBL] [Abstract][Full Text] [Related]
17. Antiplatelet Activity of a Newly Synthesized Novel Ruthenium (II): A Potential Role for Akt/JNK Signaling.
Khamrang T; Hung KC; Hsia CH; Hsieh CY; Velusamy M; Jayakumar T; Sheu JR
Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28448438
[TBL] [Abstract][Full Text] [Related]
18. Mouse antithrombotic assay. Inhibition of platelet thromboembolism by disintegrins.
Beviglia L; Poggi A; Rossi C; McLane MA; Calabrese R; Scanziani E; Cook JJ; Niewiarowski S
Thromb Res; 1993 Aug; 71(4):301-15. PubMed ID: 8236159
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of hericenone B from Hericium erinaceus on collagen-induced platelet aggregation.
Mori K; Kikuchi H; Obara Y; Iwashita M; Azumi Y; Kinugasa S; Inatomi S; Oshima Y; Nakahata N
Phytomedicine; 2010 Dec; 17(14):1082-5. PubMed ID: 20637576
[TBL] [Abstract][Full Text] [Related]
20. Antithrombotic activity of argan oil: an in vivo experimental study.
Mekhfi H; Belmekki F; Ziyyat A; Legssyer A; Bnouham M; Aziz M
Nutrition; 2012 Sep; 28(9):937-41. PubMed ID: 22465906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
